The Wyss Institute at Harvard University announced that Ropirio Therapeutics, Inc. (Ropirio) has secured a worldwide, exclusive license from Harvard’s Office of Technology Development (OTD) and Boston University (BU)’s Technology Development office for novel molecules that activate the lymphatic system.

Harvard Grid will support two postdoctoral fellows at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) in a year-long translation immersion program in its inaugural Grid Fellowship cohort.

Research in mice sheds light on how thyroid hormone alters wiring in the brain.

New printing method creates branching vessels in heart tissue that replicate the structure of human vasculature in vitro.